The three (33.3%) remaining were MSH2-positive, corresponding to two high squamous intraepithelial lesions (HSIL) and one ductal carcinoma in situ (DCIS) of the breast. This evidence concerns the gene MSH2 and squamous cell intraepithelial neoplasia.